Search the Newsreel

CAVA (CAVA) Stock Is Up, What You Need To Know

CAVA (CAVA) Stock Is Up, What You Need To Know What Happened? Shares of mediterranean fast-casual restaurant chain CAVA (NYSE:CAVA) jumped 3.8% in the afternoon session after cooling wholesale food inflation provided a favorable macroeconomic tailwind, amplifying the momentum from the company's strong second-quarter …

Wall Street Zen Upgrades Avalo Therapeutics (NASDAQ:AVTX) to Hold

Wall Street Zen has upgraded Avalo Therapeutics (NASDAQ:AVTX) from a "sell" to a "hold" rating, though the consensus among other analysts remains a "Moderate Buy" with an average price target of $45.10. The company reported a quarterly loss of $0.83 per share, missing estimates. …

What Does AvalonBay Communities (AVB) Shareholder Approval Mean For Investors?

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. AvalonBay Communities (NYSE: AVB) shareholders have approved a merger with Equity Residential to form a new company called Vivmark Residential. Equity Residential investors also backed …

Avalo Therapeutics CMO Mittie Doyle sells $13,580 in stock

Mittie Doyle, CMO at Avalo Therapeutics (NASDAQ:AVTX), sold 679 shares for $13,580 after exercising stock options under a Rule 10b5-1 trading plan. Following these transactions, she directly holds 51,776 shares and 114,413 stock options. This news follows Avalo's inclusion in the Russell 2000 and …

NVAX Stock Rises Overnight Ahead Of Q4 Print With Pfizer Tailwinds — Analyst Warns Of 20% Crash

Theravance Biopharma Deal Faces Investor Probe

Halper Sadeh LLC is investigating the proposed acquisition of Theravance Biopharma (NASDAQ: TBPH) by Zymeworks Inc. for $17 per share in cash plus a contingent value right. The investigation aims to determine if Theravance shareholders are receiving a fair price and if the company's …

Walleye Capital LLC Invests $1.53 Million in Savara Inc. $SVRA

Walleye Capital LLC has initiated a new position in Savara Inc. (NASDAQ:SVRA) by acquiring 248,720 shares valued at approximately $1.53 million during the second quarter. Despite mixed analyst sentiment, with a "Moderate Buy" consensus but recent downgrades, institutional investors collectively hold 87.93% of the …

How Stronger Margins And A Steady Dividend At Avista (AVA) Have Changed Its Investment Story

Summit Global Investments Takes Position in Avista Corporation $AVA

Summit Global Investments recently acquired a new position in Avista Corporation (NYSE:AVA) during the second quarter, purchasing 32,535 shares valued at approximately $1.33 million. This utility company is largely institutionally owned, with 85.24% of its stock held by institutional investors. Despite a cautious "Hold" …

TBPH Stock Alert: Halper Sadeh LLC is Investigating Whether Theravance Biopharma, Inc. is Obtaining a Fair Price for its Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Theravance Biopharma, Inc. (NASDAQ: TBPH) to Zymeworks Inc. for $17.00 per share. The investigation focuses on whether Theravance's board failed to secure the best possible price, conducted a fair sales process, …

Assenagon Asset Management S.A. Makes New $1.63 Million Investment in Avista Corporation $AVA

Assenagon Asset Management S.A. has initiated a new $1.63 million investment in Avista Corporation (NYSE:AVA) by purchasing 39,860 shares in the second quarter. This move comes as other institutional investors, such as Goldman Sachs and Northwestern Mutual Wealth Management Co., also significantly increased their …

Wedge Capital Management L L P NC Buys Shares of 128,845 Theravance Biopharma, Inc. $TBPH

Wedge Capital Management L L P NC recently acquired 128,845 shares of Theravance Biopharma (NASDAQ:TBPH) worth approximately $2.19 million, now owning about 0.25% of the company. Institutional investors hold 99.10% of TBPH, despite the company reporting an adjusted loss and missing revenue expectations in …

Davangere Sugar Q1 Results: Net profit rises 16% YoY to ₹588 crore

Puravankara Publishes Q1 FY2026 Unaudited Results in Newspapers

CAVA Stock: UBS Turns Bullish, Sees ‘Compelling Growth Story’ As Restaurant Expansion Gains Steam

Savara (NASDAQ:SVRA) Stock Rating Lowered by Wall Street Zen

Wall Street Zen has downgraded Savara (NASDAQ:SVRA) from a "hold" to a "sell" rating, despite a broader analyst consensus of "Moderate Buy" with a $10.14 price target. The company recently reported a quarterly loss of $0.16 per share, missing expectations, and analysts have lowered …

Avalyn Pharma (NASDAQ:AVLN) Cut to Sell at Wall Street Zen

Wall Street Zen has downgraded Avalyn Pharma (NASDAQ:AVLN) from a "hold" to a "sell" rating, despite the overall analyst sentiment being a "Moderate Buy" with a $60 average price target. Other firms like Jefferies, Guggenheim, and Evercore have issued "buy" or "outperform" ratings, while …

Davangere Sugar Company standalone net profit declines 27.69% in the June 2026 quarter

Nasdaq, S&P 500 Futures Rise Ahead Of Nvidia Earnings, Fed Minutes: Why TSLA, SLS, IBRX, CAVA, POET, BA Are In Focus

Datavault Q1 Revenue Soars 443% – CEO Touts Rising Institutional Tokenization Demand

Theravance Biopharma (TBPH): Newtyn discloses 6.7% holdings in amended 13G/A

Newtyn Management, LLC has disclosed a 6.7% beneficial ownership in Theravance Biopharma (TBPH) through an amended Schedule 13G filing. While Newtyn TE Partners, LP, a part of Newtyn Management, has reduced its holdings to below the 5% reporting threshold, Newtyn Management itself remains above …

Azevedo & Travassos Energia (AZTE3) registra prejuízo de R$ 2,5 mi no 2T26

Cava: A Rising Star in the Fast-Casual Dining Scene

Explore the exciting world of Cava(NYSE: CAVA) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities! *Stock prices used were the prices of Jun. 17, 2026. …

Azevedo & Travassos mais que dobra receita no 2º trimestre

AZEV3 Fórum | Ações Azevedo & Travassos ON - Investing.com Brasil

Cavalier Resources Reaches AU$26m Market Cap Benefiting Insider Stock Buying

Novo Holdings A/S (AVLN) discloses 8.8% beneficial stake in Avalyn Pharma

Novo Holdings A/S, an investment firm owned by the Novo Nordisk Foundation, has reported an 8.8% beneficial stake in Avalyn Pharma Inc. The firm holds 3,883,289 shares of Avalyn Pharma's voting common stock, with sole voting and dispositive power over these shares. The Novo …

Grupo Aval (AVAL) appoints new Internal Audit Manager after resignation

Cava just delivered a consumer signal Wall Street shouldn't ignore

Americans might be minding their money, but they haven't stopped dining out everywhere. Cava Group (CAVA) just sent one of the more telling signals about the status of the U.S. consumer. The Mediterranean restaurant chain reported that same-restaurant sales increased 9% in its fiscal …

Datavault AI Inc. SEC Filing (Aug 14, 2026)

Datavault AI Inc. (DVLT) has filed a Form 12b-25 Notification of Late Filing for its Quarterly Report on Form 10-Q for the quarter ended June 30, 2026. The delay is attributed to the company's recent transition to a new independent registered public accounting firm, …

CAVA (CAVA) Stock Trades Up, Here Is Why

CAVA (CAVA) Stock Trades Up, Here Is Why What Happened? Shares of mediterranean fast-casual restaurant chain CAVA (NYSE:CAVA) jumped 12.8% in the afternoon session after the company reported second-quarter results that beat analyst estimates for revenue and earnings, driven by strong sales growth. The …

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Datavault AI Inc. Investors to Secure Counsel ...

Rosen Law Firm is reminding investors of Datavault AI Inc. (NASDAQ: DVLT) who purchased securities between September 4, 2024, and October 30, 2025, about the October 5, 2026, lead plaintiff deadline for a class action lawsuit. The lawsuit alleges that Datavault AI Inc. made …

CAVA Q2 Deep Dive: Menu Innovation and Geographic Expansion Drive Growth Amid Industry Headwinds

CAVA Q2 Deep Dive: Menu Innovation and Geographic Expansion Drive Growth Amid Industry Headwinds Mediterranean fast-casual restaurant chain CAVA (NYSE:CAVA) reported Q2 CY2026 results exceeding the market's revenue expectations , with sales up 31.3% year on year to $368.4 million. Its non-GAAP profit of …